Division of Infectious Diseases at Ohio State Sue Koletar Michael J. Parisi Mercado Loved the intro today: “THE Dr. Susan Koletar from THE Ohio State University” Why is the year 1987 important? Take a listen

A beautiful morning with Team #WeBringTheScience at the AIDS Walk!

Still in need of improved screening measures but finally some much awaited guidance!

More than 80% of cardiovascular disease has been estimated to be preventable by lifestyle factors. The latest update for cancer from modifiable risk factors is ~40% acsjournals.onlinelibrary.wiley.com/doi/full/10.33… CA: A Cancer Journal for Clinicians Farhad Islami, MD PhD @ecmarlow Blake Thomson Marji McCullough Ahmedin Jemal

In the PURPOSE 1 randomized, controlled trial involving women in South Africa & Uganda, twice-yearly subcutaneous lenacapavir was superior to daily oral emtricitabine–tenofovir disoproxil fumarate in preventing HIV infection. Full trial results: nej.md/3zRElVj #AIDS2024

A great overview of my fav part of ID (how to approach newly diagnosed PWH) & the amazing social work, case management, pharmacy, patient navigation, and behavioral health support in our HIV clinic and 🌟 highlighting the clinical trials available through Ohio State AIDS Clinical Trials Unit

Effect of Obesity on the Exposure of Long-acting Cabotegravir and Rilpivirine: A Modeling Study bit.ly/4gdXLV1

Primary Care Guidance for Providers of Care for Persons With Human Immunodeficiency Virus: 2024 Update by the HIV Medicine Association of the Infectious Diseases Society of America ✅ Just Accepted 🔗 bit.ly/3BHzbfu

So fortunate to have matched such ⭐️’s! As a graduate of this fellowship program, I have nothing but positive things to say about the overall ID training, faculty, environment, and fellowship leadership (I’m a little biased but the HIV training and mentorship is 🙌🏽 💯!)

Congratulations to all of the recent ID fellow graduates who are now board certified ID physicians! Especially to our The Ohio State University Wexner Medical Center class of 2024 - Melissa Gordon, MD Dhatri Kotekal DO Petros Svoronos! Great job to all of the newly board certified ID Physicians! IDSA

Started the new year in clinic celebrating a milestone: a patient with 7+ years of uncontrolled #HIV achieving 1 year of sustained viral suppression for the first time, thanks to long-acting injectable ART 🥹🎊🎉

Cannot wait to share our passions within Infectious Diseases with you and watch you find & develop yours! 🤩🎊⭐️

The removal of #HIV- and #LGBTQ-related resources from the websites of the CDC and other health agencies is deeply concerning. Access to this information is crucial for ID and HIV health care professionals. Our full statement: bit.ly/3PYun9v

Massive cuts to funding for the National Institutes of Health will eliminate the promise of lifesaving medical treatments for millions of Americans of all ages, says IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP. Our statement: idsociety.org/news--publicat…

This decision — and other federal efforts to undermine well-established science about vaccine safety — puts everyone at risk, says IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP. Our statement in response to the cancellation of the FDA meeting: idsociety.org/news--publicat…

IDSA and HIV Medicine Association are deeply concerned by the abrupt cancellation of 92% of USAID foreign assistance awards and the impact the action will have on many. Our statement: bit.ly/41HgkvQ

Eliminating the Division of HIV Prevention at the Centers for Disease Control and Prevention would come at a cost to human lives.

📰#JIAS co-Editor-in-Chief Kenneth H. Mayer has authored a new viewpoint, detailing the consequences of U.S funding cuts that disproportionately affect #HIV research and programmes serving sexual- and gender-minority communities. Read it here: bit.ly/4kyg3Sa